Seeking AlphaTue, 23 Jun 2026 17:47:33 GMTPraxis 'Strong Buy': PDUFA In Early 2027 For Ulixacaltamide And BTD ElsunersenPRAX+1.89%
BenzingaMon, 22 Jun 2026 17:27:06 GMTPraxis' Seizure Drug Move Towards Faster Development After Positive Trial ResultsPRAX+1.89%
Seeking AlphaMon, 08 Jun 2026 20:38:31 GMTPraxis Precision Medicines, Inc. (PRAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptPRAX+1.89%
Seeking AlphaFri, 05 Jun 2026 19:23:28 GMTPraxis' Premium Price May Reflect Unrealistic Market Prospects In Essential TremorPRAX+1.89%
BenzingaTue, 02 Jun 2026 10:09:25 GMTPraxis Reassesses Vormatrigine Program After Pivotal Epilepsy Study Misses Primary EndpointPRAX+1.89%
Seeking AlphaWed, 13 May 2026 01:30:51 GMTPraxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptPRAX+1.89%
Seeking AlphaSat, 09 May 2026 17:21:17 GMTPraxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call TranscriptPRAX+1.89%
MarketBeatFri, 08 May 2026 20:15:28 GMTPraxis Precision Medicines Q1 Earnings Call HighlightsPRAX+1.89%
Investors Business DailyTue, 14 Apr 2026 15:12:08 GMTWhy Praxis, A Top 1% Biotech, Just Surged Into A Bullish BreakoutPRAX+1.89%
Seeking AlphaMon, 06 Apr 2026 20:10:15 GMTPraxis: Strong Buy As Relutrigine Submission Accepted Plus Expansion PotentialPRAX+1.89%
BenzingaMon, 06 Apr 2026 13:08:46 GMTPraxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In TrialPRAX+1.89%
